Outset Medical, Inc. (OM)
Stock Price:
$60.01 USD
1.99 (3.43%)
Updated Sep 18, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
2.46B |
| Revenue (ttm) |
28.65M |
| Net Income (ttm) |
-41.10M |
| Shares Out |
40.99M |
| EPS (ttm) |
-1.04 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Sep 18, 2020 |
| Last Price |
$60.01 |
| Previous Close |
$58.02 |
| Change ($) |
1.99 |
| Change (%) |
3.43% |
| Day's Open |
59.86 |
| Day's Range |
59.00 - 63.28 |
| Day's Volume |
421,972 |
| 52-Week Range |
49.76 - 65.00 |
More Stats
| Market Cap |
2.46B |
| Enterprise Value |
2.35B |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
40.99M |
| Float |
35.84M |
| EPS (basic) |
n/a |
| EPS (diluted) |
-1.04 |
| FCF / Share |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
85.86 |
| PB Ratio |
n/a |
| Revenue |
28.65M |
| Operating Income |
n/a |
| Net Income |
-41.10M |
| Free Cash Flow |
n/a |
| Net Cash |
106.05M |
| Net Cash / Share |
2.59 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
-143.47% |
| FCF Margin |
n/a |
| ROA |
n/a |
| ROE |
n/a |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 |
|---|
| Revenue | 15.08 | 2.01 |
| Revenue Growth | 651.27% | - |
| Gross Profit | -17.80 | -6.12 |
| Operating Income | -70.31 | -46.56 |
| Net Income | -68.30 | -49.78 |
| Shares Outstanding | 6.78 | 5.73 |
| Earnings Per Share | -12.60 | -12.75 |
| Operating Cash Flow | -70.29 | -46.44 |
| Capital Expenditures | -3.29 | -1.77 |
| Free Cash Flow | -73.59 | -48.21 |
| Cash & Equivalents | 70.08 | 143 |
| Total Debt | 29.06 | 28.36 |
| Net Cash / Debt | 41.02 | 114 |
| Assets | 88.37 | 151 |
| Liabilities | 51.11 | 49.80 |
| Book Value | -372 | -288 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Outset Medical, Inc. |
| Country |
United States |
| Employees |
273 |
| CEO |
Leslie L. Trigg |
Stock Information
| Ticker Symbol |
OM |
| Stock Exchange |
NASDAQ |
| Sector |
Health Technology |
| Industry |
Medical Specialties |
| Unique Identifier |
NASDAQ: OM |
| IPO Date |
September 15, 2020 |
Description
Outset Medical, Inc. is a medical technology company, which provides dialysis solutions to patients and healthcare providers. Its product Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.